September 23, 2019 As the heat rises, Clovis turns to radionuclides The beleaguered drug maker has licensed a preclinical FAP-directed radiopharmaceutical, a target that has made little progress.
December 23, 2016 Snippet roundup: Biogen's chief exec choice underwhelms as a big 2016 decision is delayed to 2017
